Cause of occurrence: To implement research strategy on a local level in China, OBI has accelerated to expand the potential indication for cancer cure products in Chinese market, and centralized existing resources on executed clinical projects to spread the risk of research. To avoiding resource crowding out effect to affect the original research timeline, looking for partners who are familiar with new drug development environment and market in China for co-development is a need.